Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK21542 for Moderate-to-Severe Pruritus in Peritoneal Dialysis
NCT06290375Phase 2Not yet recruiting
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Mar 2024
- Primary completion
- Mar 2024
- Modality
- Peptides, Small Molecules
01
Overview
A Phase 2 trial of hsk21542 in chronic kidney disease (CKD), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
hsk21542
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT06290375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06290375.